ACCD: Accolade, Inc. - Summary | Jitta

Accolade, Inc.

NASDAQ:ACCD

Notice
Stock data is unavailable or the company’s delisted.
Price
$7.02
Loss Chance
45.6%
4.07JITTA SCORE
27.09%Under Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (71)
Recent Business Performance (69)
Financial Strength (28)
Return to Shareholders (0)
Competitive Advantage (55)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Cash Conversion CycleLess than 30 days
Revenue and EarningEarning loss detected in 2024
Operating MarginInconsistent
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
4.07
27.09%
3.05
206.56%
Health Care Services
6.32
15.96%
8.34
56.55%
6.50
44.18%
COMPANY DESCRIPTION
Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington. As of April 8, 2025, Accolade, Inc. operates as a subsidiary of Transcarent, Inc.